Complete Genomics, Inc. (GNOM) Tops Q2 Views on Top and Bottom
Tweet Send to a FriendGet Alerts GNOM Hot Sheet
Trade GNOM Now!
Complete Genomics, Inc. (NASDAQ: GNOM) reported Q2 EPS of ($0.55), $0.03 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $7.72 million.
For earnings history and earnings-related data on Complete Genomics, Inc. (GNOM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Complete Genomics, Inc. (GNOM) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
- Hollsys (HOLI) Tops Q3 EPS by 1c; Lowers FY13 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
